Phase II Study of Ovulation in Obese Women

NCT06306131 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Pregnancy Prevention

Interventions

DRUG: Levonorgestrel 0.15 milligram
DRUG: Meloxicam 15 milligram
OTHER: calcium carbonate 750 milligram

Sponsor

InnovaGyn, Inc.

Collaborators

[object Object]